CXCL13 and myeloid sarcoma: Furthermore, CXCL13 is known to be associated with the formation of ectopic lymphoid follicles in the meninges [13], a feature of secondary progressive disease, and it is possible that all three markers represent a meningeal component of inflammation, recently shown to be present already in early MS [14].